Goldman Sachs’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-201,270
| Closed | -$63.7M | – | 4992 |
|
|
2023
Q4 | $63.7M | Buy |
201,270
+166,001
| +471% | +$52.5M | 0.01% | 856 |
|
|
2023
Q3 | $5.96M | Sell |
35,269
-58,735
| -62% | -$9.93M | ﹤0.01% | 2344 |
|
|
2023
Q2 | $20.4M | Sell |
94,004
-72,119
| -43% | -$15.6M | ﹤0.01% | 1537 |
|
|
2023
Q1 | $30.2M | Sell |
166,123
-26,434
| -14% | -$4.8M | 0.01% | 1229 |
|
|
2022
Q4 | $37.8M | Buy |
192,557
+36,311
| +23% | +$7.14M | 0.01% | 1153 |
|
|
2022
Q3 | $35.1M | Sell |
156,246
-30,631
| -16% | -$6.89M | 0.01% | 1180 |
|
|
2022
Q2 | $23.6M | Buy |
186,877
+34,922
| +23% | +$4.42M | 0.01% | 1501 |
|
|
2022
Q1 | $19.3M | Buy |
151,955
+692
| +0.5% | +$87.7K | ﹤0.01% | 1729 |
|
|
2021
Q4 | $19.8M | Sell |
151,263
-635
| -0.4% | -$83.2K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $18.6M | Sell |
151,898
-22,677
| -13% | -$2.77M | ﹤0.01% | 1789 |
|
|
2021
Q2 | $19.9M | Buy |
174,575
+25,441
| +17% | +$2.9M | ﹤0.01% | 1740 |
|
|
2021
Q1 | $17.9M | Buy |
149,134
+4,618
| +3% | +$555K | ﹤0.01% | 1758 |
|
|
2020
Q4 | $14.7M | Buy |
144,516
+52,591
| +57% | +$5.34M | ﹤0.01% | 1792 |
|
|
2020
Q3 | $7.11M | Buy |
91,925
+57,222
| +165% | +$4.42M | ﹤0.01% | 2169 |
|
|
2020
Q2 | $3.87M | Buy |
34,703
+18,459
| +114% | +$2.06M | ﹤0.01% | 2482 |
|
|
2020
Q1 | $1.17M | Buy |
16,244
+435
| +3% | +$31.3K | ﹤0.01% | 3034 |
|
|
2019
Q4 | $1.19M | Buy |
+15,809
| New | +$1.19M | ﹤0.01% | 3230 |
|
|
2019
Q3 | – | Sell |
-76,470
| Closed | -$1.53M | – | 4356 |
|
|
2019
Q2 | $1.53M | Buy |
+76,470
| New | +$1.53M | ﹤0.01% | 2941 |
|